A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...

Ifinatamab deruxtecan targets B7-H3 and is a potential first-in-class antibody-drug conjugate for extensive-stage small cell lung cancer. The FDA's Breakthrough Therapy Designation aims to expedite ...

One of the most iconic classics in the harem genre, High School DxD is what many consider the golden standard of action-comedy ecchi. Despite the series' controversial raunchiness and, at times, ...

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...

McIntosh is no stranger to digital audio. It already sells several all-in-one streaming wireless speaker systems, plus a dedicated DAC for component systems. But the DS200 brings together a unique set ...

AstraZeneca and Daiichi Sankyo confirmed today that they have decided to voluntarily withdraw their EU marketing application for datopotamab deruxtecan (Dato-DXd) in lung cancer, based on regulator ...

A new BLA for Dato-DXd targets EGFR-mutated NSCLC, following withdrawal of a previous application based on TROPION-Lung01 trial data. The new submission is supported by phase 2 TROPION-Lung05 trial ...

High School DxD season 5 has been on the anime community's radar for a while now, with several rumors circulating regarding the sequel's production. Previously, some insider sources suggested the 2024 ...